Advertisement

Current Cardiology Reports

, Volume 11, Issue 3, pp 184–191 | Cite as

End-of-life care in heart failure

  • Sarah J. Goodlin
Article

Abstract

The clinical syndrome of heart failure is increasing in prevalence, as is the number of elderly persons with heart failure. Increasing frailty and progression of heart failure in large numbers of patients means clinicians are increasingly challenged to provide end-of-life care for heart failure patients. End-of-life care has been little studied, but management can be understood from early clinical trials of advanced heart failure. Evidence-based heart failure medications, including angiotensin-converting enzyme inhibitors and β blockers, improve symptoms in patients with advanced heart failure and depressed ejection fraction and should usually be continued in end-stage disease. Patients also should have ongoing meticulous management of fluid status to maximize quality of life. End-of-life care should be planned with the patient and family and should incorporate comprehensive symptom management, bereavement support, and spiritual support. Ongoing communication with patients and families about prognosis can ease the planning of care when the end of life nears.

Keywords

Heart Failure Palliative Care Left Ventricular Ejection Fraction Continuous Positive Airway Pressure Chronic Heart Failure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Ko DT, Alter DA, Austin PC, et al.: Life expectancy after an index hospitalization for patients with heart failure: a population-based study. Am Heart J 2008, 155:324–331.PubMedCrossRefGoogle Scholar
  2. 2.
    Mozaffarian D, Anker SD, Anand I, et al.: Prediction of mode of death in heart failure: the Seattle Heart Failure Model. Circulation 2007, 116:392–398.PubMedCrossRefGoogle Scholar
  3. 3.
    Remme WJ, Cleland JG, Erhardt L, et al.: Effect of carvedilol and metoprolol on the mode of death in patients with heart failure. Eur J Heart Fail 2007, 9:1128–1135.PubMedCrossRefGoogle Scholar
  4. 4.
    Teuteberg JJ, Lewis EF, Nohria A, et al.: Characteristics of patients who die with heart failure and a low ejection fraction in the new millennium. J Card Fail 2006, 12:47–53.PubMedCrossRefGoogle Scholar
  5. 5.
    Derfler MC, Jacob M, Wolf RE, et al.: Mode of death from congestive heart failure: implications for clinical management. Am J Geriatr Cardiol 2004, 13:299–304.PubMedCrossRefGoogle Scholar
  6. 6.
    Carson P, Anand I, O’Connor C, et al.: Mode of death in advanced heart failure: the Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) trial. J Am Coll Cardiol 2005, 46:2329–2334.PubMedCrossRefGoogle Scholar
  7. 7.
    Kim DH, Hunt SA: Heart failure management: caregiver versus care plan. Circulation 2003, 108:129–131.PubMedCrossRefGoogle Scholar
  8. 8.
    Komajda M, Hanon O, Hochadel M, et al.: Management of octogenarians hospitalized for heart failure in Euro Heart Failure Survey 1. Eur Heart J 2007, 28:1310–1318.PubMedCrossRefGoogle Scholar
  9. 9.
    Yamoski LM, Hasselblad V, Moser DK, et al.: Prediction of rehospitalization and death in severe heart failure by physicians and nurses in the ESCAPE trial. J Card Fail 2007, 13:8–13.CrossRefGoogle Scholar
  10. 10.
    Lee DS, Austin PC, Rouleau JL, et al.: Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA 2003, 290:2581–2587.PubMedCrossRefGoogle Scholar
  11. 11.
    Levy WC, Mozaffarian D, Linker DT, et al.: The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation 2006, 113:1424–1433.PubMedCrossRefGoogle Scholar
  12. 12.
    Huynh BC, Rovner A, Rich MW: Identification of older patients with heart failure who may be candidates for hospice care: development of a simple four-item risk score. J Am Geriatr Soc 2008, 56:1111–1115.PubMedCrossRefGoogle Scholar
  13. 13.
    Goodlin SJ, Kutner J, Connor S, et al.: Hospice care for heart failure patients. J Pain Symptom Manag 2005, 29:525–528.CrossRefGoogle Scholar
  14. 14.
    Hauptman PJ, Swindle J, Hussain Z, et al.: Physician attitudes toward end-stage heart failure: a national survey. Am J Med 2008, 121:127–135.PubMedCrossRefGoogle Scholar
  15. 15.
    Goodlin SJ, Trupp R, Bernhardt P, et al.: Development and evaluation of the “Advanced Heart Failure Clinical Competence Survey”: a tool to assess knowledge of heart failure care and self-assessed competence. Pat Educ Couns 2007, 67:3–10.CrossRefGoogle Scholar
  16. 16.
    Allen LA, Yager JE, Fund MJ, et al.: Discordance between patient-predicted and model-predicted life expectancy among ambulatory patients with heart failure. JAMA 2008, 299:2533–2542.PubMedCrossRefGoogle Scholar
  17. 17.
    Goodlin SJ, Hauptman PJ, Arnold R, et al.: Consensus statement: Palliative and supportive care in advanced heart failure. J Card Fail 2004, 10:200–209.PubMedCrossRefGoogle Scholar
  18. 18.
    Hauptman PJ, Havranek EP: Integrating palliative care into heart failure care. Arch Intern Med 2005, 165:374–378.PubMedCrossRefGoogle Scholar
  19. 19.
    Goodlin SJ, Quill TE, Arnold RM: Communication and decision-making in heart failure. J Card Fail 2008, 14:106–113.PubMedCrossRefGoogle Scholar
  20. 20.
    A placebo-controlled trial of captopril in refractory chronic congestive heart failure. Captopril Multicenter Research Group [no authors listed]. J Am Coll Cardiol 1983:755–763.Google Scholar
  21. 21.
    Packer M, Fowler MB, Roecker EB, et al.: Effect of carvedilol on the morbidity of patients with severe chronic heart failure. Circulation 2002, 106:2194–2199.PubMedCrossRefGoogle Scholar
  22. 22.
    Krum H, Sackner-Bernstein JD, Goldsmith RL, et al.: Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure. Circulation 1995, 92:1499–1506.PubMedGoogle Scholar
  23. 23.
    Pitt B, Zannad F, Remme WJ, et al.: The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999, 341:709–717.PubMedCrossRefGoogle Scholar
  24. 24.
    Evangelista LS, Moser DK, Westlake C, et al.: Correlates of fatigue in patients with heart failure. Prog Cardiovasc Nurs 2008, 23:12–17.PubMedGoogle Scholar
  25. 25.
    Mancini DM, Katz SD, Lang CC, et al.: Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation 2003, 107:294–299.PubMedCrossRefGoogle Scholar
  26. 26.
    Colin Ramirez E, Castillo Martinez L, Orea Tejeda A, et al.: Effects of a nutritional intervention on body composition, clinical status and quality of life in patients with heart failure. Nutrition 2004, 20:890–895.PubMedCrossRefGoogle Scholar
  27. 27.
    Bradley TD, Logan AG, Kimoff RJ, et al.: Continuous positive airway pressure for central sleep apnea and heart failure. CANPAP investigators. N Engl J Med 2005, 353:2025–2033.PubMedCrossRefGoogle Scholar
  28. 28.
    Arzt M, Bradley TD: Treatment of sleep apnea in heart failure. Am J Respir Crit Care Med 2006, 173:1300–1308.PubMedCrossRefGoogle Scholar
  29. 29.
    Weber KT: Furosemide in the long-term management of heart failure. The good, the bad and the uncertain. J Am Coll Cardiol 2004, 44:1308–1310.PubMedGoogle Scholar
  30. 30.
    Conraads VM, Beckers P, Vaes J, et al.: Combined endurance/resistance training reduces NT-proBNP levels in patients with chronic heart failure. Eur Heart J 2004, 25:1797–1805.PubMedCrossRefGoogle Scholar
  31. 31.
    Beniaminovitz A, Lang CC, LaManca J, Mancini DM: Selective low-level leg muscle training alleviates dyspnea in patients with heart failure. J Am Coll Cardiol 2002, 40:1602–1608.PubMedCrossRefGoogle Scholar
  32. 32.
    Belardinelli R, Georgiou D, Cianci G, et al.: Randomized controlled trial of long-term moderate exercise training in chronic heart failure: effects on functional capacity, quality of life and clinical outcome. Circulation 1999, 99:1173–1182.PubMedGoogle Scholar
  33. 33.
    Johnson MJ: Morphine for the relief of breathlessness in patients with chronic heart failure Eur Heart J 2002, 4:753–756.CrossRefGoogle Scholar
  34. 34.
    Chua TP, Harrington D, Ponikowski P, et al.: Effects of dihydrocodeine on chemosensitivity and exercise tolerance in patients with chronic heart failure. J Am Coll Cardiol 1997, 29:147–152.PubMedCrossRefGoogle Scholar
  35. 35.
    Williams SG, Wright DJ, Marshall P, et al.: Safety and potential benefits of low dose diamorphine during exercise in patients with chronic heart failure. Heart 2003, 89:1085–1086.PubMedCrossRefGoogle Scholar
  36. 36.
    Weir MR: Renal effects of nonselective NSAIDs and coxibs. Cleve Clin J Med 2002, 69:SI53–SI58.PubMedCrossRefGoogle Scholar
  37. 37.
    Page J, Henry D: Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an under-recognized public health problem. Arch Intern Med 2000, 160:777–784.PubMedCrossRefGoogle Scholar
  38. 38.
    Mamdani M, Juurlink DN, Lee DS, et al.: Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study. Lancet 2004, 363:1751–1756.PubMedCrossRefGoogle Scholar
  39. 39.
    Hryniewicz K, Androne AS, Hudaihed A, Katz SD: Partial reversal of cachexia by beta-adrenergic receptor blocker therapy in patients with chronic heart failure. J Card Fail 2003, 9:464–468.PubMedCrossRefGoogle Scholar
  40. 40.
    Anker SD, Negassa A, Coats AJ, et al.: Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting enzyme inhibitors: an observational study. Lancet 2003, 361:1077–1083.PubMedCrossRefGoogle Scholar
  41. 41.
    Archana R, Gray D: The quality of life in chronic disease—heart failure is as bad as it gets. Eur Heart J 2002, 23:1806–1808.PubMedCrossRefGoogle Scholar
  42. 42.
    Murray SA, Kendall M, Boyd K, et al.: Exploring the spiritual needs of people dying of lung cancer or heart failure: a prospective qualitative interview study of patients and their carers. Palliat Med 2004, 18:39–45.PubMedCrossRefGoogle Scholar
  43. 43.
    Horne G, Payne S: Removing the boundaries: palliative care for patients with heart failure Palliat Med 2004, 18:291–296.PubMedCrossRefGoogle Scholar
  44. 44.
    Gillian R, Pulchalski CM: Spiritual support in heart failure patients. In Supportive Care in Heart Failure. Edited by Beattie J, Goodlin SJ. New York, NY: Oxford University Press; 2008:299–318.Google Scholar
  45. 45.
    Puchalski C, Romer AL: Taking a spiritual history allows clinicians to understand patients more fully. J Palliat Med 2000, 3:129–137.PubMedCrossRefGoogle Scholar
  46. 46.
    Sullivan M, Levy WC, Russo JE, Spertus JA: Depression and health status in patients with advanced heart failure: a prospective study in tertiary care. J Card Fail 2004, 10:390–396.PubMedCrossRefGoogle Scholar
  47. 47.
    Bekelman DB, Sullivan M: Depression and anxiety in patients with chronic heart failure. In Supportive Care in Heart Failure. Edited by Beattie J, Goodlin SJ. New York, NY: Oxford University Press; 2008:273–298.Google Scholar
  48. 48.
    Stuart B, Alexander C, Arenella C, et al.; for Standards and Accreditation Committee, Medical Guidelines Task Force: Medical Guidelines for Determining Prognosis in Selected Non-Cancer Diseases. Arlington, VA: National Hospice Organization; 1996.Google Scholar
  49. 49.
    Hauptman PJ, Goodlin SJ, Lopatin M: Characteristics of patients hospitalized with acute decompensated heart failure who are referred for hospice care. Arch Intern Med 2007, 167:1990–1997.PubMedCrossRefGoogle Scholar
  50. 50.
    Hershberger RE, Nauman D, Walker TL, et al.: Care processes and clinical outcomes of continuous outpatient support with inotropes (COSI) in patients with refractory endstage heart failure. J Card Fail 2003, 9:180–187.PubMedCrossRefGoogle Scholar

Copyright information

© Current Medicine Group, LLC 2009

Authors and Affiliations

  1. 1.Patient-centered Education and ResearchSalt Lake CityUSA

Personalised recommendations